Get the Stockscreener App
1.24
3.33%
0.04
After Hours:
1.24
Immunic Inc Stock (IMUX) Forecast
The Immunic Inc (IMUX) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $0.4939, representing a -60.17% decrease from the current price of $1.24. The highest analyst price target is $0.9718, and the lowest is $0.0159.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month IMUX Price Target
Average 7.5781
(+511.13% Upside)
Is Immunic Inc (IMUX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 52.64 | Neutral |
| STOCH(9,6) | 52.32 | Neutral |
| STOCHRSI(14) | 100.00 | Sell |
| MACD(12,26) | -0.0492 | Buy |
| ADX(14) | 26.12 | Buy |
| William %R | -20.00 | Sell |
| CCI(14) | 80.15 | Neutral |
Buy: 2
Sell: 2
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.122
Buy
|
1.1595
Buy
|
| MA20 |
1.149
Buy
|
1.1838
Buy
|
| MA50 |
1.3575
Sell
|
1.2853
Sell
|
| MA100 |
1.3961
Sell
|
1.3329
Sell
|
| MA200 |
1.334
Sell
|
1.355
Sell
|
Buy: 4
Sell: 6
Neutral: 0
Summary: Sell
According to our latest analysis, IMUX could be considered a Moderate Sell, with 17 technical analysis indicators signaling 6 Buy signals, 8 signaling Sell signals and 3 Neutral signals. This might not be a good time to consider opening new positions on IMUX, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 52.64 indicates that IMUX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 52.32 indicates that IMUX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100 indicates that IMUX is oversold. This suggests that IMUX price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 26.12 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 80.15 indicates that IMUX is still overbought but not to an extreme extent.
Long-term IMUX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Immunic Inc financial reports and earnings history, Immunic Inc (IMUX) stock could reach $10.63 by 2030, $8.0561 by 2040 and $15.17 by 2050. See the projected annual prices until 2050 of the Immunic Inc stock below:
- Immunic Inc (IMUX) is expected to reach an average price of $3.0238 in 2035, with a high prediction of $3.2694 and a low estimate of $3.0738. This indicates an $143.86% rise from the last recorded price of $1.24.
- Immunic Inc (IMUX) stock is projected to chart a bullish course in 2040, with an average price target of $7.7544, representing an $525.36% surge from its current level. The forecast ranges from a conservative $7.9344 to a sky-high $8.0561.
- Our analysts predict Immunic Inc (IMUX) to jump 933.04% by 2045, soaring from $13.48 to an average price of $12.81, potentially reaching $13.26. While $13.48 is the low estimate, the potential upside is significant.
- Immunic Inc (IMUX) stock is expected to climb by 2050, reaching an average of $14.28, a $1,052% jump from its current level. However, a wide range of estimates exists, with high and low targets of $15.17 and $16.09, respectively, highlighting the market's uncertainty.
Immunic Inc Stock (IMUX) Year by Year Forecast
Immunic Inc Stock (IMUX) Price Forecast for 2025
Immunic Inc Stock (IMUX) is expected to reach an average price of $7.5781 in 2025, with a high prediction of $15.14 and a low estimate of $0.0159. This indicates an +511.13% rise from the last recorded price of $1.24.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $0.174 | $0.0159 | $0.9718 | -85.97% |
| February, 2025 | $0.8782 | $0.4119 | $0.6599 | -29.18% |
| March, 2025 | $1.5404 | $0.7043 | $0.3237 | +24.23% |
| April, 2025 | $3.0707 | $1.8384 | $1.8572 | +147.63% |
| May, 2025 | $0.1929 | $0.4229 | $2.0687 | -84.45% |
| June, 2025 | $1.1849 | $0.3609 | $3.3349 | -4.44% |
| July, 2025 | $5.2647 | $0.367 | $5.9627 | +324.57% |
| August, 2025 | $3.8924 | $3.0905 | $8.0066 | +213.91% |
| September, 2025 | $10.45 | $3.4044 | $15.14 | +742.76% |
| October, 2025 | $5.63 | $5.245 | $12.53 | +354.03% |
| November, 2025 | $10.61 | $5.3319 | $11.40 | +755.46% |
| December, 2025 | $8.0375 | $7.6975 | $12.92 | +548.19% |
Immunic Inc Stock (IMUX) Price Forecast for 2026
The predicted value for Immunic Inc (IMUX) in 2026 is set at an average of $11.11. Estimates vary from a peak of $20.95 to a trough of $1.2612, indicating an +795.79% surge from the present price of $1.24.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $9.8753 | $6.5894 | $14.08 | +696.39% |
| February, 2026 | $10.12 | $9.3792 | $11.68 | +716.38% |
| March, 2026 | $10.47 | $7.517 | $11.18 | +744.02% |
| April, 2026 | $9.5906 | $8.6548 | $20.95 | +673.44% |
| May, 2026 | $8.5684 | $5.8746 | $11.32 | +591.00% |
| June, 2026 | $7.9662 | $6.4003 | $9.9862 | +542.43% |
| July, 2026 | $5.6559 | $4.744 | $8.742 | +356.12% |
| August, 2026 | $7.4837 | $5.4879 | $8.4037 | +503.53% |
| September, 2026 | $5.9835 | $4.9976 | $8.0857 | +382.54% |
| October, 2026 | $2.8012 | $1.2612 | $6.6154 | +125.91% |
| November, 2026 | $3.549 | $2.4832 | $3.884 | +186.21% |
| December, 2026 | $2.6988 | $2.6688 | $4.211 | +117.64% |
Immunic Inc Stock (IMUX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Immunic Inc (IMUX) is $4.5312, with a high forecast of $9.0616 and a low forecast of $0.000843. This indicates an +265.42% increase from the last price of $1.24.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $2.5766 | $0.8827 | $4.0907 | +107.79% |
| February, 2027 | $3.4844 | $2.3385 | $4.5505 | +181.00% |
| March, 2027 | $3.8341 | $2.3883 | $4.0441 | +209.20% |
| April, 2027 | $6.2519 | $3.3899 | $6.8819 | +404.18% |
| May, 2027 | $7.9197 | $3.8758 | $9.0038 | +538.68% |
| June, 2027 | $5.3494 | $4.9194 | $9.0616 | +331.40% |
| July, 2027 | $6.1172 | $4.6314 | $7.0172 | +393.32% |
| August, 2027 | $3.045 | $2.36 | $7.5198 | +145.56% |
| September, 2027 | $1.2147 | $0.000843 | $3.3769 | -2.04% |
| October, 2027 | $1.1775 | $1.0867 | $1.5067 | -5.04% |
| November, 2027 | $0.3397 | $1.2297 | $1.0566 | -72.61% |
| December, 2027 | $0.7701 | $0.00226 | $1.0101 | -37.90% |
Immunic Inc Stock (IMUX) Price Forecast for 2028
In 2028, Immunic Inc (IMUX) is projected to reach an average price of $3.8349, with a high projection of $7.5995 and a low estimate of $0.0702. This indicates an +209.26% rise from the last price of $1.24.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.1878 | $0.1322 | $1.082 | -84.85% |
| February, 2028 | $1.0644 | $0.0702 | $0.5845 | -14.16% |
| March, 2028 | $2.2946 | $0.5996 | $7.5995 | +85.05% |
| April, 2028 | $2.5968 | $2.5427 | $2.4868 | +109.42% |
| May, 2028 | $2.4771 | $2.5429 | $2.5049 | +99.77% |
| June, 2028 | $1.7893 | $2.1893 | $2.2901 | +44.30% |
| July, 2028 | $1.4815 | $1.2335 | $1.3174 | +19.48% |
| August, 2028 | $1.7018 | $1.4837 | $1.4371 | +37.24% |
| September, 2028 | $1.844 | $1.7297 | $1.7159 | +48.71% |
| October, 2028 | $1.4462 | $1.5362 | $1.652 | +16.63% |
| November, 2028 | $1.3665 | $1.3484 | $1.2665 | +10.20% |
| December, 2028 | $0.3087 | $1.2926 | $1.1606 | -75.11% |
Immunic Inc Stock (IMUX) Price Forecast for 2029
The 2029 price forecast for Immunic Inc Stock (IMUX) is $3.8006 on average, with a high prediction of $7.60 and a low estimate of $0.00128. This represents an +206.50% increase from the previous price of $1.24.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.2489 | $0.2548 | $0.3233 | -79.93% |
| February, 2029 | $0.8811 | $0.637 | $0.7511 | -28.94% |
| March, 2029 | $0.9733 | $0.7872 | $0.8133 | -21.50% |
| April, 2029 | $1.0656 | $1.0094 | $0.8514 | -14.07% |
| May, 2029 | $1.0558 | $1.1058 | $1.0897 | -14.85% |
| June, 2029 | $0.788 | $0.8176 | $0.8939 | -36.45% |
| July, 2029 | $0.3602 | $0.4502 | $0.7061 | -70.95% |
| August, 2029 | $0.5105 | $0.4883 | $0.5325 | -58.83% |
| September, 2029 | $0.3527 | $0.4027 | $0.4185 | -71.56% |
| October, 2029 | $0.093 | $0.0869 | $0.1631 | -92.50% |
| November, 2029 | $0.1052 | $0.0671 | $0.1448 | -91.52% |
| December, 2029 | $9.25 | $0.00128 | $7.60 | +645.97% |
Immunic Inc Stock (IMUX) Price Forecast for 2030
Immunic Inc Stock (IMUX) is expected to reach an average price of $8.8657 in 2030, with a high forecast of $11.55 and a low forecast of $6.1821. This signifies an +614.98% surge from the last price of $1.24.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $11.26 | $11.42 | $10.63 | +808.11% |
| February, 2030 | $6.6049 | $10.22 | $10.78 | +432.66% |
| March, 2030 | $6.8294 | $7.1694 | $6.3094 | +450.75% |
| April, 2030 | $3.3038 | $6.3938 | $6.5605 | +166.43% |
| May, 2030 | $9.4143 | $6.1821 | $7.8853 | +659.22% |
| June, 2030 | $10.65 | $10.03 | $10.39 | +758.77% |
| July, 2030 | $12.36 | $10.92 | $11.16 | +896.71% |
| August, 2030 | $10.76 | $11.36 | $11.55 | +768.04% |
| September, 2030 | $9.3281 | $9.3519 | $9.3998 | +652.26% |
| October, 2030 | $9.2722 | $9.684 | $9.4364 | +647.76% |
| November, 2030 | $11.65 | $10.11 | $9.7669 | +839.84% |
| December, 2030 | $11.17 | $12.46 | $10.96 | +800.60% |
1.61%
1.14%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):